The $20 million deal, expected to close in the second half of 2019, includes the acquisition of Johnstown-based Ohio Grown Therapies’ cultivation and processing facilities and licenses.
For more details, click here.
Get access to more in-depth market analysis, premium features on cannabis investing trends and monthly executive webcasts with an Investor Intelligence subscription.